Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypnosis for Quality of Life in Crohn's Disease
NCT03623932Unknown
- Sponsor
- CHU Grenoble Alpes
- Start
- Nov 2018
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Randomised, open-label trial in Crohn's disease (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Inflammatory Bowel Disease Questionnaire at 6 months. Status: unknown.
02
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT03623932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03623932.